Ionis Pharmaceuticals, Inc.
CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE

Last updated:

Abstract:

The present disclosure provides duplexes comprising a first oligomeric compound and a second oligomeric compound wherein the second oligomeric compound comprises a conjugate group. In certain embodiments, the duplex modulates the amount or activity of a target nucleic acid in extra hepatic tissues and/or extra hepatic cells. In certain embodiments, the duplex modulates the amount or activity of a target nucleic acid in hepatic tissues and/or hepatic cells.

Status:
Application
Type:

Utility

Filling date:

10 Aug 2021

Issue date:

27 Jan 2022